Cargando…
Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons
Pertussis continues to cause considerable infant mortality world-wide, which could be addressed in part by passive immunization strategies. Antibody hu1B7 is a candidate therapeutic that potently neutralizes pertussis toxin in vitro, prevents leukocytosis in mice and treats established disease in we...
Autores principales: | Nguyen, Annalee W., DiVenere, Andrea M., Papin, James F., Connelly, Sheila, Kaleko, Michael, Maynard, Jennifer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002138/ https://www.ncbi.nlm.nih.gov/pubmed/32076653 http://dx.doi.org/10.1126/sciadv.aay9258 |
Ejemplares similares
-
Passive Immunization with Anti-Pertussis Toxin Humanized Monoclonal Antibody Mitigates Clinical Signs of Pertussis Infection in Newborn Baboons
por: Maynard, Jennifer, et al.
Publicado: (2017) -
Prior exposure to Bordetella species as an exclusion criterion in the baboon model of pertussis
por: NGUYEN, Annalee W., et al.
Publicado: (2016) -
Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking
por: Acquaye‐Seedah, Edith, et al.
Publicado: (2018) -
Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis
por: DiVenere, Andrea M., et al.
Publicado: (2022) -
Antibodies binding diverse pertactin epitopes protect mice from Bordetella pertussis infection
por: Silva, Rui P., et al.
Publicado: (2022)